Updated Recommendations on the Use of Anthrax Vaccine in the United States
The CDC’s Prevention’s Advisory Committee on Immunization Practices updated recommendations regarding the use of anthrax vaccine in the US.
Vaccines
Mandatory Vaccination Ups Prevalence of Vaccine Coverage
Measles, pertussis vaccination increased in European countries with mandatory vaccination.
Accelerated Dengue/Yellow Fever Vaccine Schedule Noninferior to Conventional Schedule
Study data demonstrates an early benefit to receiving Japanese Encephalitis vaccination prior to CYD-TDV in terms of higher overall anti-dengue virus neutralizing titers, although this benefit appears to wane after several months.
M72/AS01 Tuberculosis Vaccine Remains Efficacious After 3 years
The M72/AS01 vaccine shows efficacy against pulmonary tuberculosis (TB) at 3 years in patients with Mycobacterium tuberculosis infection.
Few MMR-Vaccine Eligible Children Receive Vaccine Before Travel
41.3 percent of MMR vaccination-eligible pediatric travelers received MMR vaccine at pretravel consultation.
Annual Reported Measles Incidence Dropped From 2000 to 2018
Measles vaccination averted an estimated 23.2 million deaths during 2000 to 2018.
CDC: PCV13 No Longer Routinely Recommended for Adults ≥65
The 13-valent pneumococcal conjugate vaccine is no longer recommended for routine use among adults aged ≥65 years.
Pneumococcal Vaccine in Older Adults: A Primary Care Approach to Increasing Uptake
Because of low vaccination rates, approximately 5.6 million cases of community-acquired pneumonia occur in the United States annually.
Too Few Women Receive Influenza and Tdap Vaccines During Pregnancy, CDC Says
Only 1 in 3 mothers-to-be receive both influenza and Tdap vaccines, according to a CDC report.
Studies Confirm Safety of 9-Valent HPV Vaccination
Studies based on searching Vaccine Adverse Event Reporting System, 6 Vaccine Safety Datalink sites.
Next post in Infectious Diseases Information Center
